China’s Biotech Revolution
Our China Healthcare Analyst Jack Lin discusses how China’s biotech surge is reshaping healthcare, investment and innovation worldwide. Read more insights from Morgan Stanley. ----- Transcript ----- Jack Lin: Welcome to Thoughts on the Market. I'm Jack Lin, from Morgan Stanley's China Healthcare Team. Today, the boom…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
Similar episodes from other shows
More like Thoughts on the Market →
Here Comes the Booming Chinese Biotech Sector
57%China's booming biotech, from a brain implant to drug discovery
Longevity: Can We Add Another 30 Years? | The Decade Ahead
The Shift in Global Drug Development
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.